Non-Fatal Overdose Among a Cohort of Active Injection Drug Users Recruited from a Supervised Injection Facility

REFERENCES

• Davidson P, McLean R, Kral A, Gleghorn A, Edlin B, Moss A. Fatal heroin-related overdose in San Francisco, 1997–2000: A case for targeted intervention. Journal of urban health : bulletin of the New York Academy of Medicine 2003; 80(2)261–273
   PubMed Web of Science ®Google Scholar
• Fischer B, Brissette S, Brochu S, Bruneau J, el-Guebaly N, Noël L, Rehm J, Tyndall M, Wild C, Mun P, Haydon E, Baliunas D. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 2004; 171(3)235–239
   PubMed Web of Science ®Google Scholar
• Morgan O, Griffiths C, Hickman M. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993–2004. International journal of epidemiology 2006; 35(6)1579–1585
   PubMed Web of Science ®Google Scholar
• Prevention, C.f.D.C.a. Unintentional poisoning deaths-United States, 1999–2004. Morbidity and mortality weekly report 2007; 56(5)93–96
   PubMedGoogle Scholar
• Coffin P, Galea S, Ahern J, Leon A, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction 2003; 98(6)739–747
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Roxburgh A, Barker B. Underlying causes of cocaine, amphetamine and opioid related deaths in Australia. Journal of clinical forensic medicine 2005; 12(4)187–195
   PubMedGoogle Scholar
• Hickman M, Carrivick S, Paterson S, Hunt N, Zador D, Cusick L, Henry J. London audit of drug-related overdose deaths: Characteristics and typology, and implications for prevention and monitoring. Addiction 2007; 102(2)317–323
   PubMedGoogle Scholar
• Bargagli A, Sperati A, Davoli M, Forastiere F, Perucci C. Mortality among problem drug users in Rome: An 18-year follow-up study, 1980–97. Addiction 2001; 96(10)1455–1463
   PubMed Web of Science ®Google Scholar
• Darke S, Zador D. Fatal heroin ‘overdose’: A review. Addiction 1996; 91(12)1765–1772
   PubMed Web of Science ®Google Scholar
• Hulse G, English D, Milne E, Holman C. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999; 94(2)221–229
   PubMed Web of Science ®Google Scholar
• Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: A 22-year follow-up study. Addiction 1994; 89(10)1299–1308
   PubMed Web of Science ®Google Scholar
• Darke S, Hetherington K, Ross J, Lynskey M, Teesson M. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev 2004; 23(2)177–183
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend 2007; 87(1)39–45
   PubMed Web of Science ®Google Scholar
• Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction 2002; 97(8)963–967
   PubMed Web of Science ®Google Scholar
• Kerr T, Wood E, Grafstein E, Ishida T, Shannon K, Lai C, Montaner J, Tyndall M. High rates of primary care and emergency department use among injection drug users in Vancouver. J Pub Health (Oxf) 2005; 27(1)62–66
   PubMed Web of Science ®Google Scholar
• Darke S, Williamson A, Ross J, Teesson M. Non-fatal heroin overdose, treatment exposure and client characteristics: Findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev 2005; 24(5)425–432
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Montaner J, Strathdee S, Wodak A, Hankins C, Schechter M, Tyndall M. Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis 2004; 4(5)301–306
   PubMed Web of Science ®Google Scholar
• Poschade S, Höger R, Schnitzler J. Evaluation der Arbeit der Drogenkonsumräume in der Bundesrepublik Deutschland. Nomos, Baden-BadenGermany 2003
   Google Scholar
• Agency, B.C.V.S. Health status indicators in British Columbia: Birth-related and mortality statistics(1991–1995). Ministry of Health, Vancouver 1996
   Google Scholar
• Agency, B.C.V.S. Health status indicators in British Columbia: Birth-related and mortality statistics (1995–1999). Ministry of Health Planning, Vancouver 2001
   Google Scholar
• Greenblatt J. Year-end preliminary estimates from 1996. 1997, Drug Abuse Network, Network, Washington, D.C.
   Google Scholar
• Hall W, Degenhardt L, Lynskey M. Opioid overdose mortality in Australia, 1964–1997: Birth-cohort trends. Med J Aust 1999; 171(1)34–37
   PubMedGoogle Scholar
• Office of the Chief Coroner Statistics: 2002–2007: Illicit drug deaths. B.C. Coroners, Service, Vancouver 2007, Ministry of Public Safety and Solicitor-General
   Google Scholar
• Kerr T, Tyndall M, Lai C, Montaner J, Wood E. Drug-related overdoses within a medically supervised safer injection facility. InternJ Drug Pol 2006; 17: 436–441
   Web of Science ®Google Scholar
• van Beek I, Dakin A, Kimber J, Gilmour S. The Sydney medically supervised injecting centre: Reducing harm associated with heroin overdose. CritPub Health 2004; 14(4)391–406
   Google Scholar
• Selby P, Kahan M, Srivastava A. Safe Injecting Sites (SIS): Need for equipose and evidence of net benefit to illicit drug users. Canadian Medical Association Journal 2007, eLetters 2 February, 2007
   Google Scholar
• Health Canada. Insite given six-month extension says Minister Clement. Health Canada. 2007
   Google Scholar
• Tyndall M, Wood E, Zhang R, Lai C, Montaner J, Kerr T. HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: Implications for prevention, care and treatment. Harm Reduct J 2006; 3: 36
   PubMedGoogle Scholar
• Wood E, Tyndall M, Li K, Lloyd-Smith E, Small W, Montaner J, Kerr T. Do supervised injecting facilities attract higher risk injection drug users?. Am J Prev Med 2005; 29(2)126–130
   PubMed Web of Science ®Google Scholar
• Coffin P, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. AcadEmerge Med 2007; 14(7)616–623
   Google Scholar
• Ochoa K, Davidson P, Evans J, Hahn J, Page–Shafer K, Moss A. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend 2005; 80(3)297–302
   PubMed Web of Science ®Google Scholar
• Bennett G, Higgins D. Accidental overdose among injecting drug users in Dorset, UK. Addiction 1999; 94(8)1179–1189
   PubMedGoogle Scholar
• Wood E, Tyndall M, Quo Z, Zhang R, Montaner J, Kerr T. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. Am J Pub Health 2006; 96(5)770–773
   PubMed Web of Science ®Google Scholar
• Wood E, Tyndall M, Stoltz J, Small W, Zhang R, O'Connell J, Montaner J, Kerr T. Safer injecting education for HIV prevention within a medically supervised safer injecting facility. Intern J Drug Pol 2005; 16: 281–284
   Web of Science ®Google Scholar
• Coroner, O.o.t.C. Statistics (2002–2007): Illicit drug deaths. British Columbia Coroners Service, Vancouver 2007, Ministry of Public Safety and Solicitor-General
   Google Scholar
• Wood E, Stoltz J, Li K, Montaner J, Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction 2006; 101(5)689–695
   PubMedGoogle Scholar
• Stoltz J, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Pub Health (Oxf) 2007; 29(1)35–39
   PubMed Web of Science ®Google Scholar
• Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005; 80(3)329–335
   PubMed Web of Science ®Google Scholar
• Kilbourne A, Herndon B, Andersen R, Wenzel S, Gelberg L. Psychiatric symptoms, health services, and HIV risk factors among homeless women. J Health Care Poor Underserv 2002; 13(1)49–65
   PubMed Web of Science ®Google Scholar
• O'Connell J, Kerr T, Li K, Tyndall M, Hogg R, Montaner J, Wood E. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr 2005; 40(1)83–88
   PubMed Web of Science ®Google Scholar
• Wood E, Spittal P, Kerr T, Small W, Tyndall M., O'Shaughnessy M., Schechter M. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Can J Pub Health 2003; 94(5)355–359
   PubMed Web of Science ®Google Scholar
• Wood E, Tyndall M, Spittal P, Li K, Kerr T, Hogg R, Montaner J, O'Shaughnessy M, Schechter M. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. CMAJ 2001; 165(4)405–410
   PubMed Web of Science ®Google Scholar
• McKnight I, Maas B, Wood E, Tyndall M, Small W, Lai C, Montaner J, Kerr T. Factors associated with public injecting among users of Vancouver's supervised injection facility. American J Drug Alcohol Abuse 2007; 33(2)319–325
   PubMed Web of Science ®Google Scholar
• Dietze P, Jolley D, Fry C, Bammer G. Transient changes in behaviour lead to heroin overdose: Results from a case-crossover study of non-fatal overdose. Addiction 2005; 100(5)636–642
   PubMed Web of Science ®Google Scholar
• Siegel S, Hinson R, Krank M, McCully J. Heroin “overdose” death: Contribution of drug-associated environmental cues. Science 1982; 216(4544)436–437
   PubMedGoogle Scholar
• Christie T, Wood E, Schechter M, O'Shaughnessy M. A comparison of the new federal guidelines regulating supervised injection site research in Canada and the Tri-Council Policy Statement on Ethical Conduct for Research Involving Human Subjects. Intern J Drug Pol 2003; 15(1)66–73
   Google Scholar